8 results on '"Carla Garcia"'
Search Results
2. Sorting of secretory proteins at the trans-Golgi network by human TGN46
- Author
-
Pablo Lujan, Carla Garcia-Cabau, Yuichi Wakana, Javier Vera Lillo, Carmen Rodilla-Ramírez, Hideaki Sugiura, Vivek Malhotra, Xavier Salvatella, Maria F Garcia-Parajo, and Felix Campelo
- Subjects
membrane trafficking ,protein secretion ,Golgi apparatus ,Medicine ,Science ,Biology (General) ,QH301-705.5 - Abstract
Secretory proteins are sorted at the trans-Golgi network (TGN) for export into specific transport carriers. However, the molecular players involved in this fundamental process remain largely elusive. Here, we identified the human transmembrane protein TGN46 as a receptor for the export of secretory cargo protein PAUF in CARTS – a class of protein kinase D-dependent TGN-to-plasma membrane carriers. We show that TGN46 is necessary for cargo sorting and loading into nascent carriers at the TGN. By combining quantitative fluorescence microscopy and mutagenesis approaches, we further discovered that the lumenal domain of TGN46 encodes for its cargo sorting function. In summary, our results define a cellular function of TGN46 in sorting secretory proteins for export from the TGN.
- Published
- 2024
- Full Text
- View/download PDF
3. Biochar as an Alternative Litter Additive to Mitigate Gaseous Emissions from Broiler Housing and Subsequent Storage
- Author
-
José L. S. Pereira, Filipa Martins, Gabriel Bonifácio, Carla Garcia, José Teixeira, and Henrique Trindade
- Subjects
aluminum ,ammonia ,biochar ,broiler farming ,greenhouse gases ,urease inhibitor ,Agriculture - Abstract
Broiler farming is a significant source of gaseous emissions. The aim of this study was to assess the effects of different litter additives on the emission of NH3, N2O, CO2, and CH4 during broiler housing and subsequent manure storage. The gaseous emissions from the housing facilities were evaluated during one fattening cycle in environmentally controlled rooms with three different additives applied to the litter material (10% w/w aluminum sulphate or biochar and 2.50 mg m−2 urease inhibitor), as well as a control. A storage experiment was conducted under laboratory conditions for 90 days to evaluate the influence of these three additives on gaseous losses. During broiler housing, the results indicated that NH3 emissions were reduced significantly (40–60%) by litter additives, while global warming potential (GWP) emissions were reduced significantly (31%) by Alum. The addition of Biochar (a 58% reduction) had the same significant effect as Alum (a 60% reduction) to mitigate these losses. The re-application of Urease (a 41% reduction) may be required to reach an equal or higher reduction. During storage, NH3 and GWP emissions were not significantly affected by the litter additives. During broiler housing and subsequent manure storage, NH3 emissions were reduced significantly (22–41%) by litter additives, whereas GWP emissions did not decrease significantly. Globally, it can be concluded that Biochar appears to be a good alternative to Alum due to its equal effectiveness in mitigating NH3 losses, without increasing the GWP potential in the housing and avoiding pollution swapping.
- Published
- 2024
- Full Text
- View/download PDF
4. Cannabis use disorder contributes to cognitive dysfunction in Veterans with traumatic brain injury
- Author
-
Aryan Esmaeili, Clara Dismuke-Greer, Terri K. Pogoda, Megan E. Amuan, Carla Garcia, Ariana Del Negro, Maddy Myers, Eamonn Kennedy, David Cifu, and Mary Jo Pugh
- Subjects
traumatic brain injury ,cannabis use disorder ,dementia ,Veterans ,Cox proportional hazards model ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
BackgroundWhile emerging evidence supports a link between traumatic brain injury (TBI) and progressive cognitive dysfunction in Veterans, there is insufficient information on the impact of cannabis use disorder (CUD) on long-term cognitive disorders. This study aimed to examine the incidences of cognitive disorders in Veterans with TBI and CUD and to evaluate their relationship.MethodsThis retrospective cohort study used the US Department of Veterans Affairs and Department of Defense administrative data from the Long-term Impact of Military-Relevant Brain Injury Consortium-Chronic Effects of Neurotrauma Consortium Phenotype study. Diagnoses suggesting cognitive disorders after a TBI index date were identified using inpatient and outpatient data from 2003 to 2022. We compared the differential cognitive disorders incidence in Veterans who had the following: (1) no CUD or TBI (control group), (2) CUD only, (3) TBI only, and (4) comorbid CUD+TBI. Kaplan-Meier analyses were used to estimate the overall cognitive disorders incidence in the above study groups. The crude and adjusted Cox proportional hazards models were used to estimate crude and adjusted hazard ratios (HRs) for cognitive disorders.ResultsA total of 1,560,556 Veterans [82.32% male, median (IQR) age at the time of TBI, 34.51 (11.29) years, and 61.35% white] were evaluated. The cognitive disorder incidence rates were estimated as 0.68 (95% CI, 0.62, 0.75) for CUD only and 1.03 (95% CI, 1.00, 1.06) for TBI only per 10,000 person-months of observations, with the highest estimated cognitive disorder incidence observed in participants with both TBI and CUD [1.83 (95% CI, 1.72, 1.95)]. Relative to the control group, the highest hazard of cognitive disorders was observed in Veterans with CUD+TBI [hazard ratio (HR), 3.26; 95% CI, 2.91, 3.65], followed by those with TBI only (2.32; 95 CI%, 2.13, 2.53) and with CUD (1.79; 95 CI%, 1.60, 2.00). Of note, in the CUD only subgroup, we also observed the highest risk of an early onset cognitive disorder other than Alzheimer's disease and Frontotemporal dementia.DiscussionThe results of this analysis suggest that individuals with comorbid TBI and CUD may be at increased risk for early onset cognitive disorders, including dementia.
- Published
- 2024
- Full Text
- View/download PDF
5. The economic impact of cannabis use disorder and dementia diagnosis in veterans diagnosed with traumatic brain injury
- Author
-
Aryan Esmaeili, Terri K. Pogoda, Megan E. Amuan, Carla Garcia, Ariana Del Negro, Maddy Myers, Mary Jo Pugh, David Cifu, and Clara Dismuke-Greer
- Subjects
traumatic brain injury ,cannabis use disorder ,dementia ,veterans ,costs ,economic burden ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
BackgroundStudies have demonstrated that individuals diagnosed with traumatic brain injury (TBI) frequently use medical and recreational cannabis to treat persistent symptoms of TBI, such as chronic pain and sleep disturbances, which can lead to cannabis use disorder (CUD). We aimed to determine the Veterans Health Administration (VHA) healthcare utilization and costs associated with CUD and dementia diagnosis in veterans with TBI.MethodsThis observational study used administrative datasets from the population of post-9/11 veterans from the Long-term Impact of Military-Relevant Brain Injury Consortium-Chronic Effects of Neurotrauma Consortium and the VA Data Warehouse. We compared the differential VHA costs among the following cohorts of veterans: (1) No dementia diagnosis and No CUD group, (2) Dementia diagnosis only (Dementia only), (3) CUD only, and (4) comorbid dementia diagnosis and CUD (Dementia and CUD). Generalized estimating equations and negative binomial regression models were used to estimate total annual costs (inflation-adjusted) and the incidence rate of healthcare utilization, respectively, by dementia diagnosis and CUD status.ResultsData from 387,770 veterans with TBI (88.4% men; median [interquartile range (IQR)] age at the time of TBI: 30 [14] years; 63.5% white) were followed from 2000 to 2020. Overall, we observed a trend of gradually increasing healthcare costs 5 years after TBI onset. Interestingly, in this cohort of veterans within 5 years of TBI, we observed substantial healthcare costs in the Dementia only group (peak = $46,808) that were not observed in the CUD and dementia group. Relative to those without either condition, the annual total VHA costs were $3,368 higher in the CUD only group, while no significant differences were observed in the Dementia only and Dementia and CUD groups.DiscussionThe findings suggest that those in the Dementia only group might be getting their healthcare needs met more quickly and within 5 years of TBI diagnosis, whereas veterans in the Dementia and CUD group are not receiving early care, resulting in higher long-term healthcare costs. Further investigations should examine what impact the timing of dementia and CUD diagnoses have on specific categories of inpatient and outpatient care in VA and community care facilities.
- Published
- 2024
- Full Text
- View/download PDF
6. Prevalence of Cryptococcal Antigenemia and Lateral Flow Assay Accuracy in Severely Immunosuppressed AIDS Patients.
- Author
-
Negri, Adriana Carla Garcia, Nunes, Maína de Oliveira, Lima, Gláucia Moreira Espíndola, Venturini, James, de Oliveira, Sandra Maria do Valle Leone, Lazera, Márcia dos Santos, Carvalho, Lídia Raquel de, Chang, Marilene Rodrigues, Tsujisaki, Rosianne Assis de Sousa, França, Adriana de Oliveira, Mendes, Rinaldo Poncio, and Paniago, Anamaria Mello Miranda
- Subjects
- *
AIDS patients , *RHEUMATOID factor , *IMMUNOCOMPROMISED patients , *HIV infections , *POINT-of-care testing - Abstract
This study aimed to estimate the prevalence of cryptococcal antigenemia detected by lateral flow assay (LFA) in AIDS patients and its accuracy in the diagnosis of cryptococcosis. Conducted at a university hospital in Brazil from March 2015 to July 2017, it included AIDS patients over 18 years old with a CD4+ count ≤ 200 cells/mm3. Cryptococcal antigen (CrAg) detection using LFA and latex agglutination (LA), along with blood and urine cultures, were performed. The reference standard was the identification of Cryptococcus spp. in clinical specimens through microbiological or histopathological examination. Among 230 patients, the prevalence of CrAg detected by LFA (CrAg LFA) was 13.0%. Factors associated with cryptococcal antigenemia included fever, vomiting, seizures, and a lack of antiretroviral therapy. The sensitivity and specificity of CrAg LFA were 83.9% and 98.0%, respectively. The positive predictive value (PPV) was 86.7%, the negative predictive value (NPV) was 97.5%, and overall accuracy was 96.1%. Cross-reactions were observed in patients with histoplasmosis and paracoccidioidmycosis, but not with aspergillosis or positive rheumatoid factor. The study concludes that the LFA is a useful tool for detecting cryptococcal antigenemia in severely immunocompromised AIDS patients due to its high NPV, specificity, and PPV. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Description of a national, multi‐center registry of patients with sickle cell disease and SARS‐CoV‐2 infection: Data from the Pediatric COVID‐19 United States Registry.
- Author
-
Dain, Aleksandra S., Diorio, Caroline, Fisher, Brian T., Hankins, Jane S., Witmer, Char M., Boustany, Mickael, Burton, Madeline, Ferrolino, Jose, Sadaf, Salma, Ross, Hailey S., Maron, Gabriela, Ardura, Monica I., Arnold, Sandra, Celentano, Donna, Custodio, Haidee, Danziger‐Isakov, Lara, Enane, Leslie, Foster, Catherine, Furstenau, Dana, and Carreno, Carla Garcia
- Published
- 2024
- Full Text
- View/download PDF
8. Prevalence of Cryptococcal Antigenemia and Lateral Flow Assay Accuracy in Severely Immunosuppressed AIDS Patients
- Author
-
Adriana Carla Garcia Negri, Maína de Oliveira Nunes, Gláucia Moreira Espíndola Lima, James Venturini, Sandra Maria do Valle Leone de Oliveira, Márcia dos Santos Lazera, Lídia Raquel de Carvalho, Marilene Rodrigues Chang, Rosianne Assis de Sousa Tsujisaki, Adriana de Oliveira França, Rinaldo Poncio Mendes, and Anamaria Mello Miranda Paniago
- Subjects
cryptococcosis ,HIV infection ,immunocromatography ,point-of-care systems ,Biology (General) ,QH301-705.5 - Abstract
This study aimed to estimate the prevalence of cryptococcal antigenemia detected by lateral flow assay (LFA) in AIDS patients and its accuracy in the diagnosis of cryptococcosis. Conducted at a university hospital in Brazil from March 2015 to July 2017, it included AIDS patients over 18 years old with a CD4+ count ≤ 200 cells/mm3. Cryptococcal antigen (CrAg) detection using LFA and latex agglutination (LA), along with blood and urine cultures, were performed. The reference standard was the identification of Cryptococcus spp. in clinical specimens through microbiological or histopathological examination. Among 230 patients, the prevalence of CrAg detected by LFA (CrAg LFA) was 13.0%. Factors associated with cryptococcal antigenemia included fever, vomiting, seizures, and a lack of antiretroviral therapy. The sensitivity and specificity of CrAg LFA were 83.9% and 98.0%, respectively. The positive predictive value (PPV) was 86.7%, the negative predictive value (NPV) was 97.5%, and overall accuracy was 96.1%. Cross-reactions were observed in patients with histoplasmosis and paracoccidioidmycosis, but not with aspergillosis or positive rheumatoid factor. The study concludes that the LFA is a useful tool for detecting cryptococcal antigenemia in severely immunocompromised AIDS patients due to its high NPV, specificity, and PPV.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.